Jana Partners LLC Trimmed Boston Scientific Corp (BSX) Stake as Share Price Rose

Boston Scientific Corporation (NYSE:BSX) LogoInvestors sentiment increased to 1.2 in Q2 2018. Its up 0.24, from 0.96 in 2018Q1. It increased, as 38 investors sold BSX shares while 177 reduced holdings. 92 funds opened positions while 167 raised stakes. 1.21 billion shares or 2.60% more from 1.18 billion shares in 2018Q1 were reported. Thrivent For Lutherans holds 0.02% in Boston Scientific Corporation (NYSE:BSX) or 216,056 shares. Sivik Healthcare Lc reported 3.27% in Boston Scientific Corporation (NYSE:BSX). 17,400 were accumulated by Tributary Cap Mgmt Lc. Guggenheim Cap Ltd Company invested in 143,042 shares. Ww Asset invested 0.15% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Huntington National Bank stated it has 20,252 shares or 0.01% of all its holdings. Moreover, Howe And Rusling has 0% invested in Boston Scientific Corporation (NYSE:BSX) for 31 shares. Arizona State Retirement Sys has 449,811 shares for 0.15% of their portfolio. Sumitomo Mitsui Asset Mgmt Ltd holds 148,918 shares or 0.07% of its portfolio. Kbc Group Nv invested in 0.2% or 708,171 shares. Tru Of Vermont invested in 5,127 shares or 0.02% of the stock. United Fincl Advisers Limited Liability Corp holds 21,370 shares. First Mercantile Trust Com accumulated 6,400 shares or 0.04% of the stock. Hgk Asset holds 235,322 shares or 1.44% of its portfolio. Meyer Handelman Com, a New York-based fund reported 26,400 shares.

Since June 7, 2018, it had 0 insider purchases, and 20 sales for $20.51 million activity. On Thursday, November 29 Thepaut Eric Francis Yves sold $562,019 worth of Boston Scientific Corporation (NYSE:BSX) or 15,298 shares. 1,500 Boston Scientific Corporation (NYSE:BSX) shares with value of $54,965 were sold by Carruthers Wendy. Mirviss Jeffrey B. sold $630,703 worth of stock. Another trade for 116,666 shares valued at $4.19M was sold by Mahoney Michael F. $154,000 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Butcher Arthur C. The insider Nanavaty Maulik sold $874,446.

Jana Partners Llc decreased its stake in Boston Scientific Corp (BSX) by 33.59% based on its latest 2018Q2 regulatory filing with the SEC. Jana Partners Llc sold 1.59M shares as the company’s stock rose 14.84% with the market. The hedge fund held 3.14 million shares of the medical and dental instruments company at the end of 2018Q2, valued at $102.60M, down from 4.72 million at the end of the previous reported quarter. Jana Partners Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $49.10B market cap company. The stock decreased 3.51% or $1.29 during the last trading session, reaching $35.48. About 7.40 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 25.61% since December 8, 2017 and is uptrending. It has outperformed by 9.99% the S&P500.

Jana Partners Llc, which manages about $11.37 billion and $3.78 billion US Long portfolio, upped its stake in Agilent Technologies Inc (NYSE:A) by 198,168 shares to 1.22 million shares, valued at $75.49M in 2018Q2, according to the filing. It also increased its holding in Dr Pepper Snapple Group Inc (Call) (NYSE:DPS) by 1.71M shares in the quarter, for a total of 2.30 million shares, and has risen its stake in Spdr S&P 500 Etf Tr (SPY).

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 7. They expect $0.37 earnings per share, up 8.82 % or $0.03 from last year’s $0.34 per share. BSX’s profit will be $512.00M for 23.97 P/E if the $0.37 EPS becomes a reality. After $0.35 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 5.71 % EPS growth.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Seekingalpha.com which released: “Medtronic slips 2% premarket on device injuries – Seeking Alpha” on November 26, 2018, also Forbes.com with their article: “MedSurg Will Likely Drive Boston Scientific’s Near-Term Earnings Growth – Forbes” published on November 29, 2018, Seekingalpha.com published: “Boston Scientific Corporation (BSX) Management on Citi’s 2018 Global Healthcare Conference Call (Transcript) – Seeking Alpha” on December 06, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Bizjournals.com and their article: “Boston Scientific to buy British medical device firm for $4.2B – Boston Business Journal” published on November 20, 2018 as well as Benzinga.com‘s news article titled: “Jim Cramer Gives His Opinion On Boston Scientific, MongoDB And More – Benzinga” with publication date: November 28, 2018.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 10 analysts covering Boston Scientific Corp (NYSE:BSX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Boston Scientific Corp had 11 analyst reports since June 12, 2018 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Tuesday, September 4. Canaccord Genuity maintained the shares of BSX in report on Thursday, October 25 with “Buy” rating. As per Monday, September 17, the company rating was maintained by Wells Fargo. As per Tuesday, September 4, the company rating was maintained by Raymond James. The firm has “Buy” rating by Argus Research given on Friday, October 26. Morgan Stanley maintained it with “Overweight” rating and $48 target in Tuesday, October 2 report. The company was maintained on Thursday, July 26 by Morgan Stanley.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.